Dr David C Garrett Iii, MD in Rogers, AR - Medicare Family Practice

Dr David C Garrett Iii, MD is a medicare enrolled "Family Medicine" physician in Rogers, Arkansas. He went to University Of Arkansas College Of Medicine and graduated in 1976 and has 48 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Advanced Health And Wellness Llc and his current practice location is 613 N 2nd St, Rogers, Arkansas. You can reach out to his office (for appointments etc.) via phone at (479) 878-1060.

Dr David C Garrett Iii is licensed to practice in Arkansas (license number C-5192) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1265489421.

Contact Information

	Dr David C Garrett Iii, MD
	613 N 2nd St, Rogers, AR 72756-6611
	(479) 878-1060
	(479) 878-1070

Physician's Profile

Full Name	Dr David C Garrett Iii
Gender	Male
Speciality	Family Practice
Experience	48 Years
Location	613 N 2nd St, Rogers, Arkansas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr David C Garrett Iii attended and graduated from University Of Arkansas College Of Medicine in 1976

NPI Data:

NPI Number: 1265489421
Provider Enumeration Date: 05/30/2006
Last Update Date: 07/02/2015

Medicare PECOS Information:

PECOS PAC ID: 1951340967
Enrollment ID: I20050428001069

Medical Identifiers

Medical identifiers for Dr David C Garrett Iii such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1265489421	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	C-5192 (Arkansas)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Advanced Health And Wellness Llc	4880004688	2

News Archive

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

Geron Corporation today announced several presentations at the American Association for Cancer Research Special Conference on The Role of Telomeres and Telomerase in Cancer Research held in Fort Worth, TX between February 27th and March 1st.

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

In a recent study, a group of researchers discuss the functional implications of this specific S protein mutation on SARS-CoV-2.

Low-cost lab-on-a-chip diagnostic tests become attractive area of research

Scientists in Australia are reporting the first use of ordinary cotton thread and sewing needles to literally stitch together a microfluidic analytical device - microscopic technology that can transport fluids for medical tests and other purposes in a lab-on-a-chip.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr David C Garrett Iii allows following entities to bill medicare on his behalf.

Entity Name	Precision Health Care, Inc.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1902298342 PECOS PAC ID: 7719025352 Enrollment ID: O20150414000500

News Archive

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

In a recent study, a group of researchers discuss the functional implications of this specific S protein mutation on SARS-CoV-2.

Low-cost lab-on-a-chip diagnostic tests become attractive area of research

Entity Name	Advanced Health & Wellness Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1740897693 PECOS PAC ID: 4880004688 Enrollment ID: O20201106000408

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

In a recent study, a group of researchers discuss the functional implications of this specific S protein mutation on SARS-CoV-2.

Low-cost lab-on-a-chip diagnostic tests become attractive area of research

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David C Garrett Iii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr David C Garrett Iii, MD 613 N 2nd St, Rogers, AR 72756-6611 Ph: (479) 878-1060	Dr David C Garrett Iii, MD 613 N 2nd St, Rogers, AR 72756-6611 Ph: (479) 878-1060

News Archive

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

In a recent study, a group of researchers discuss the functional implications of this specific S protein mutation on SARS-CoV-2.

Low-cost lab-on-a-chip diagnostic tests become attractive area of research

Family Medicine Doctors in Rogers, AR

Anthony Meloy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4305 S Pleasant Crossing Blvd Ste 3, Rogers, AR 72758 Phone: 479-289-8376
Dr. John Newland Redwine, DO, FAAFP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 24 Bracebridge Rd, Rogers, AR 72756 Phone: 479-871-1981
Dr. Dustin Paul Pope, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5206 W Village Pkwy Ste 10, Rogers, AR 72758 Phone: 479-657-6600 Fax: 479-657-6632
Dr. Andrew White, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2710 S Rife Medical Ln, Rogers, AR 72758 Phone: 479-338-8000
Shelby Wigginton, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2708 S Rife Medical Ln Ste 130, Rogers, AR 72758 Phone: 479-338-5555 Fax: 479-338-5533
Dr. Amanda Marie Ferguson Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2708 S Rife Medical Ln, Rogers, AR 72758 Phone: 479-338-5555 Fax: 479-338-5533
Martin A Hannon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3730 S Pinnacle Hills Pkwy Ste 2, Rogers, AR 72758 Phone: 479-464-5599 Fax: 479-464-5598

Dr David C Garrett Iii, MD - Medicare Family Practice in Rogers, AR

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

Low-cost lab-on-a-chip diagnostic tests become attractive area of research

Medicare Reassignments

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

Low-cost lab-on-a-chip diagnostic tests become attractive area of research

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

Low-cost lab-on-a-chip diagnostic tests become attractive area of research

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

The effect of novel insertion mutation in SARS-CoV-2 spike glycoprotein RNA

Low-cost lab-on-a-chip diagnostic tests become attractive area of research

Family Medicine Doctors in Rogers, AR